Related Experiment Video
Updated: Aug 11, 2026

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice
Published on: March 17, 2014
Type III protein secretion is associated with death in lower respiratory and systemic Pseudomonas aeruginosa
A Roy-Burman1, R H Savel, S Racine
1Department of Anesthesia and Perioperative Care, Cardiovascular Research Institute, University of California, San Francisco, CA 94143-0542, USA.
Abstract:
The ability of Pseudomonas aeruginosa to secrete specific toxins using the type III-mediated pathway has been reported. To determine the association of this phenotype with human illness, immunoblot analysis was used to detect expression of type III secretory proteins in P. aeruginosa isolates from respiratory tract or blood cultures of 108 consecutive patients. Relative risk of mortality was 6-fold greater with expression of the type III secretory proteins ExoS, ExoT, ExoU, or PcrV. Phenotype was independently correlated with toxicity in cellular and murine models. Prevalence of this phenotype was significantly higher in acutely infected patients than in chronically infected patients with cystic fibrosis. These results suggest that the type III protein secretion system is integral to increased P. aeruginosa virulence. A positive phenotype is a predictor of poor clinical outcome. In the future, such analyses may help distinguish potentially lethal infection from colonization and help determine appropriate therapy for critically ill patients.
Insights
Pseudomonas aeruginosa expressing type III secretory proteins like ExoS and ExoT significantly increases mortality risk in patients. This finding highlights the type III secretion system
Area of Science:
- Microbiology
- Pathogenesis
- Clinical Research
Background:
- Pseudomonas aeruginosa can secrete toxins via the type III secretion system.
- The clinical significance of this pathway in human infections is not fully understood.
Purpose of the Study:
- To investigate the association between type III secretory protein expression in P. aeruginosa and patient outcomes.
- To evaluate the role of the type III secretion system in P. aeruginosa virulence.
Main Methods:
- Immunoblot analysis was used to detect type III secretory proteins (ExoS, ExoT, ExoU, PcrV) in P. aeruginosa isolates from 108 patients.
- Toxicity was assessed in cellular and murine models.
- Phenotype prevalence was compared between acute and chronic infections.
Main Results:
- Expression of type III secretory proteins was associated with a 6-fold increased relative risk of mortality.
- The phenotype correlated with increased toxicity in experimental models.
- The prevalence of this phenotype was higher in acutely infected patients compared to chronically infected cystic fibrosis patients.
Conclusions:
- The type III protein secretion system is crucial for P. aeruginosa virulence.
- Detecting this phenotype can predict poor clinical outcomes.
- This analysis may aid in differentiating lethal infections from colonization and guiding therapy.
Related Concept Videos
Pneumonia II: Pathophysiology
Acute Respiratory Failure-III
Gram-negative Bacterial Protein Secretion Systems
Gene Regulation in Microbial Communities: Quorum Sensing
Atypical Pneumonia
Pneumonia I: Introduction

